Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test PML Ra Ra t(15:17), Qualitative Test is 7 days.

What are the prerequisites for the test PML Ra Ra t(15:17), Qualitative Test

  • Specimen: Bone marrow or peripheral blood
  • Container: Lavender top (EDTA) tube for peripheral blood or green top (heparin) tube for bone marrow
  • Collection: Collect sample in aseptic conditions
  • Storage: Store sample at room temperature and send to the laboratory as soon as possible
  • Preparation: No special preparation required

What are the measure values for the test PML Ra Ra t(15:17), Qualitative Test

  • Positive
  • Negative

What does this test PML Ra Ra t(15:17), Qualitative Test identify?

This test, PML Ra Ra t(15:17), is a qualitative test that identifies the presence of a specific genetic abnormality known as the t(15:17) translocation. This translocation is a rearrangement of genetic material between chromosomes 15 and 17, and is commonly associated with a type of leukemia called acute promyelocytic leukemia (APL).

By detecting the t(15:17) translocation, this test can help diagnose APL and guide treatment decisions. The presence of this genetic abnormality is often used to determine the prognosis of APL and to monitor response to treatment.

Why is this test PML Ra Ra t(15:17), Qualitative Test taken?

Reason for taking PML Ra Ra t(15:17), Qualitative Test

The PML-RARα t(15:17) test is taken to detect a specific genetic abnormality known as the PML-RARα fusion gene. This abnormality is commonly associated with acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML).

By detecting the presence of the PML-RARα fusion gene through this qualitative test, healthcare providers can confirm a diagnosis of APL and determine the appropriate treatment plan for the patient. This test is important for guiding treatment decisions as APL requires a different approach compared to other types of AML.

No FAQs available.

Customer Google Rating